US2022181022A1PendingUtilityA1

Health management devices and methods

Assignee: ABBOTT DIABETES CARE INCPriority: Jun 21, 2007Filed: Feb 22, 2022Published: Jun 9, 2022
Est. expiryJun 21, 2027(~0.9 yrs left)· nominal 20-yr term from priority
G16H 40/63G16H 40/67G16H 50/20A61B 2560/0223A61B 5/0031A61B 5/002A61B 5/0002G16H 20/10G08C 17/02A61B 2560/0252A61B 5/14865A61B 5/14542A61B 2560/0276G16Z 99/00A61B 5/14546A61B 2560/045A61B 2560/0456G16H 10/60G06Q 50/22A61B 5/0017G16H 10/40A61B 5/14532H04L 67/12
80
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and devices and systems include generating analyte data based on signals from an analyte sensor transcutaneously positioned in contact with interstitial fluid under a skin layer of a user and to generate signals corresponding to an analyte level of a target analyte. The analyte data corresponds to the analyte level of the target analyte over a wear period. Methods include storing the analyte data over the wear period. Methods include determining one or more indications based on the analyte data. Methods include determining a reimbursement insurance code based at least in part on stored sensor information associated with the analyte sensor. Methods include communicating at least a portion of the analyte data and the reimbursement insurance code to an electronic record associated with the user and stored by a remote electronic medical record system. Methods include providing the one or more indications on a user interface unit.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An integrated analyte monitoring and medical record system, comprising:
 a remote electronic medical record system configured to store an electronic record associated with a user;   a data processing system communicatively coupled with the remote electronic medical record system;   an analyte sensor configured to be transcutaneously positioned at least in part in contact with an interstitial fluid under a skin layer of a user and to generate electrical signals corresponding to an analyte level of a target analyte;   a data collection module communicatively coupled to the analyte sensor and configured to generate and store analyte data based on the electrical signals over a wear period, the data collection module further storing sensor information associated with the analyte sensor;   a user interface unit communicatively coupled to the data collection module and configured to provide one or more indications related to the analyte data;   a control unit communicatively coupled to the data collection module and the user interface unit and configured to control, at least in part, operation of the data collection module and the user interface unit; and   a communication module coupled to the control unit and configured to communicate the sensor information and at least a portion of the analyte data to the data processing system, wherein:
 the data processing system is configured to determine a reimbursement insurance code based at least in part on the sensor information and further communicate the at least a portion of the analyte data and the reimbursement insurance code to the electronic record associated with the user stored by the remote electronic medical record system. 
   
     
     
         2 . The integrated analyte monitoring and medical record system of  claim 1 , wherein the communication module is further configured to communicate with the data processing system after the analyte data is generated and stored by the data collection module and after the expiration of the wear period. 
     
     
         3 . The integrated analyte monitoring and medical record system of  claim 1 , wherein the communication module is further configured to communicate with the data processing system using one or more of a wired connection or a wireless connection. 
     
     
         4 . The integrated analyte monitoring and medical record system of  claim 3 , wherein the communication module is configured to communicate with the data processing system using the wired connection, and wherein the wired connection comprises a USB cable connection or a serial cable connection. 
     
     
         5 . The integrated analyte monitoring and medical record system of  claim 3 , wherein the communication module is configured to communicate with the data processing system using the wireless connection, and wherein the wireless connection comprises use of a radio frequency (RF) communication protocol. 
     
     
         6 . The integrated analyte monitoring and medical record system of  claim 3 , wherein the communication module is configured to communicate with the data processing system using the wireless connection, and wherein the wireless connection comprises use of a Bluetooth communication protocol. 
     
     
         7 . The integrated analyte monitoring and medical record system of  claim 1 , wherein the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information related to the generated analyte data. 
     
     
         8 . The integrated analyte monitoring and medical record system of  claim 7 , wherein the information related to the generated analyte data includes graphical output corresponding to the analyte level. 
     
     
         9 . The integrated analyte monitoring and medical record system of  claim 1 , wherein the user interface unit is configured to operate in a retrospective analysis mode including limited output of information during the wear period such that the user interface unit is configured to not display information related to the generated analyte data during the wear period. 
     
     
         10 . The integrated analyte monitoring and medical record system of  claim 9 , wherein the limited output of information during the retrospective analysis mode includes output to the user interface unit of operational status information. 
     
     
         11 . The integrated analyte monitoring and medical record system of  claim 9 , wherein the limited output of information during the retrospective analysis mode includes output to the user interface unit of time of day information. 
     
     
         12 . The integrated analyte monitoring and medical record system of  claim 9 , wherein the limited output of information during the retrospective analysis mode includes output to the user interface unit of an elapsed duration of the wear period. 
     
     
         13 . The integrated analyte monitoring and medical record system of  claim 1 , wherein the analyte data is stored by the data collection module as uncalibrated analyte data. 
     
     
         14 . The integrated analyte monitoring and medical record system of  claim 13 , wherein the analyte data is calibrated prior to the data processing system communicating the one or more signals associated with the analyte data to the electronic record associated with the user stored by the remote electronic medical record system. 
     
     
         15 . The integrated analyte monitoring and medical record system of  claim 1 , wherein the sensor information comprises a unique identifier associated with the analyte sensor. 
     
     
         16 . A method, comprising:
 generating analyte data based on electrical signals from an analyte sensor configured to be transcutaneously positioned at least in part in contact with an interstitial fluid under a skin layer of a user and to generate electrical signals corresponding to an analyte level of a target analyte, wherein the analyte data corresponds to the analyte level of the target analyte over a wear period;   storing the analyte data corresponding to the analyte level over the wear period;   determining one or more indications based on the analyte data corresponding to the analyte level over the wear period;   determining a reimbursement insurance code based at least in part on stored sensor information associated with the analyte sensor;   communicating at least a portion of the analyte data and the reimbursement insurance code to an electronic record associated with the user and stored by a remote electronic medical record system; and   providing the one or more indications on a user interface unit.   
     
     
         17 . The method of  claim 16 , wherein the at least a portion of the analyte data is communicated to the electronic record after the expiration of the wear period. 
     
     
         18 . The method of  claim 16 , further comprising calibrating the analyte data prior to determining the one or more indications based on the analyte data. 
     
     
         19 . The method of  claim 16 , further comprising providing a unique patient identifier to the electronic medical record system prior to communicating the at least a portion of the analyte data to the electronic record associated with the user. 
     
     
         20 . The method of  claim 16 , further comprising causing the user interface unit to operate in a retrospective analysis mode, wherein the retrospective analysis mode includes limited output of information during the wear period such that the user interface unit is configured to not display information related to the generated analyte data during the wear period.

Join the waitlist — get patent alerts

Track US2022181022A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.